News

Transformative R01 FOA Released

RFA-RM-08-029

• LOIs: due December 29, 2008
• Applications: due January 29, 2009
• Earliest startdate: September 1, 2009

A major goal of the NIH is to foster bold and creative investigator-initiated research. The NIH has created the Transformative Research Projects Program (T-R01) to enhance submission and support of exceptionally innovative, high risk, original and/or unconventional research that has the potential to create new or challenge existing scientific paradigms. The T-R01 program will be piloting novel approaches to peer review and program management to facilitate identification and support of groundbreaking advances, unproven concepts and truly transformative ideas.

The NIH encourages T-R01 applications from scientists representing all disciplines relevant to the NIH mission, including the biological, behavioral, clinical, social, physical, chemical, computational, engineering, and mathematical sciences.

Areas of highlighted need in RFA-RM-08-029 that have been identified through an NIH strategic planning process include:

• Understanding and facilitating behavior change
• Formulation of novel protein capture reagents
• Functional variation in mitochondria in disease
• Complex 3-Dimensional tissue models
• Transitions from acute to chronic pain
• Providing an evidence base for pharmacogenomics

Additional information about the Transformative R01 Program and a link to the current FOA is available at the NIH Roadmap for Medical Research.

The NIH Roadmap for Medical Research, launched in 2004, is a series of initiatives designed to address fundamental knowledge gaps, develop transformative tools and technologies, and/or foster innovative approaches to complex problems. Funded through the NIH Common Fund, these programs cut across the missions of individual NIH Institutes and Centers (ICs) and are intended to accelerate the translation of research to improvements in public health. OPASI, in collaboration with all NIH ICs, oversees programs funded by the Common Fund. Additional information about the NIH Roadmap and Common Fund can be found at www.nihroadmap.nih.gov.

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH.

Seeding Collaborative Interdisciplinary Team Science in Diabetes, Endocrinology and Metabolic Diseases (R24) Department of Health and Human Services

Full Announcement

The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 06/18/2008 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.

If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.

Synopsis

Document Type: Grants Notice
Funding Opportunity Number: PAR-08-181
Opportunity Category: Discretionary
Posted Date: Jun 18, 2008
Creation Date: Jun 18, 2008
Original Closing Date for Applications: Sep 07, 2011
Current Closing Date for Applications: Sep 07, 2011
Archive Date: Oct 08, 2011
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
CFDA Number: 93.847 -- Diabetes, Endocrinology and Metabolism Research
Cost Sharing or Matching Requirement: No

Eligible Applicants

• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Public and State controlled institutions of higher education
• Private institutions of higher education

Additional Information on Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Tribally Controlled Colleges and Universities (TCCUs).

Agency Name

National Institutes of Health

Description

Purpose. The purpose of the Seeding Collaborative Interdisciplinary Team Science Program described in this announcement is to provide initial support to enable strong new investigative teams to form, and to foster preliminary research activities. It is anticipated that research teams receiving seeding support under this program will be well positioned to compete for funds through the parent NIDDK Collaborative Interdisciplinary Research Program in Diabetes, Endocrinology and Metabolic Diseases solicitation (see PAR-08-182).

Mechanism of Support. This FOA will utilize the Resource Research (R24) grant mechanism.

Funds Available and Anticipated Number of Awards. It is anticipated that 5-10 projects will be funded, but because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism num bers, quality, duration, and costs of the applications received.

If you have difficulty accessing the full announcement electronically, please contact the NIH OER Webmaster.

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster.

Synopsis Modification History

There are currently no modifications for this opportunity.